Number of items: 10.
Jokl, E,
Mullan, AF,
Simpson, K,
Birchall, L,
Pearmain, L,
Martin, K,
Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061,
Raza, S,
Shah, R,
Hodson, NW,
Williams, CJ,
Camacho, E,
Zeef, L,
Donaldson, I,
Athwal, VS,
Hanley, NA and
Piper Hanley, K ORCID: https://orcid.org/0000-0001-9473-9647
(2023)
PAK1-dependent mechanotransduction enables myofibroblast nuclear adaptation and chromatin organization during fibrosis.
Cell Reports, 42 (11).
ISSN 2211-1247
Verran, J ORCID: https://orcid.org/0000-0002-5539-6896, Illingworth, S, Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061 and Redfern, J ORCID: https://orcid.org/0000-0003-0958-683X
(2023)
Co-development, co-delivery, and evaluation of a Medical Writing module at master’s level.
Medical Writing, 32 (1).
pp. 92-98.
ISSN 2047-4806
Silvagnoli, LM, Shepherd, C, Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061 and Gardner, J
(2022)
Optimizing Readability and Format of Plain Language Summaries for Medical Research Articles: Cross-sectional Survey Study.
Journal of Medical Internet Research, 24 (1).
ISSN 1438-8871
Raza, S,
Jokl, E,
Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061,
Martin, K,
Su, K,
Simpson, K,
Birchall, L,
Mullan, AF,
Athwal, VS,
Doherty, DT,
Zeef, L,
Henderson, NC,
Kalra, PA,
Hanley, NA and
Hanley, KP
(2021)
SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function.
Science Signaling, 14 (672).
ISSN 1945-0877
Redfern, J ORCID: https://orcid.org/0000-0003-0958-683X, Ratova, M, Dean, AP, Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061, Grao, M, Verran, J ORCID: https://orcid.org/0000-0002-5539-6896 and Kelly, P ORCID: https://orcid.org/0000-0003-1008-4941
(2020)
Visible light photocatalytic bismuth oxide coatings are effective at suppressing aquatic cyanobacteria and degrading free-floating genomic DNA.
Journal of Environmental Sciences, 104.
pp. 128-136.
ISSN 0253-2468
Athwal, VS,
Pritchett, J ORCID: https://orcid.org/0000-0003-2620-7061,
Llewellyn, J,
Martin, K,
Camacho, E,
Raza, SMA,
Phythian‐Adams, A,
Birchall, LJ,
Mullan, AF,
Su, K,
Pearmain, L,
Dolman, G,
Zaitoun, AM,
Friedman, SL,
MacDonald, A,
Irving, WL,
Guha, IN,
Hanley, NA and
Piper Hanley, K
(2017)
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.
EMBO Molecular Medicine, 9 (12).
pp. 1696-1710.
ISSN 1757-4676
Martin, K,
Pritchett, J,
Llewellyn, J,
Mullan, AF,
Athwal, VS,
Dobie, R,
Harvey, E,
Zeef, L,
Farrow, S,
Streuli, C,
Henderson, NC,
Friedman, SL,
Hanley, NA and
Piper Hanley, K
(2016)
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.
Nature Communications, 7.
ISSN 2041-1723
Pritchett, J,
Athwal, VS,
Harvey, E,
Martin, K,
Llewellyn, J,
Ireland, P,
Nicolaides, A,
Humphries, MJ,
Bobola, N,
Hanley, NA and
Piper Hanley, K
(2014)
Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells.
PloS one, 9 (6).
ISSN 1932-6203
Pritchett, J,
Harvey, E,
Athwal, V,
Berry, A,
Rowe, C,
Oakley, F,
Moles, A,
Mann, DA,
Bobola, N,
Sharrocks, AD,
Thomson, BJ,
Zaitoun, AM,
Irving, WL,
Guha, IN,
Hanley, NA and
Hanley, KP
(2012)
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.
Hepatology, 56 (3).
pp. 1108-1116.
ISSN 0270-9139
Pritchett, J, Wright, C, Zeef, L and Nadarajah, B
(2007)
Stromal derived factor-1 exerts differential regulation on distinct cortical cell populations in vitro.
BMC Developmental Biology, 7.
ISSN 1471-213X
This list was generated on Tue Nov 19 05:06:40 2024 GMT.